openPR Logo
Press release

Induced Pluripotent Stem Cell (iPSC) Market Growth, Size, Trends, Size, Share And Analysis Report 2024-2033

Induced Pluripotent Stem Cell (iPSC) Market

Induced Pluripotent Stem Cell (iPSC) Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The induced pluripotent stem cell (ipsc) market size has grown rapidly in recent years. It will grow from $2.97 billion in 2023 to $3.29 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing healthcare expenditure, a rise in funding, rising awareness of stem cell products' medicinal potential, use of induced pluripotent stem cell (ipsc) based drug discovery, increasing demand for personalized medicine and cost-effective benefits of ipsc for drug discovery.

The induced pluripotent stem cell (ipsc) market size is expected to see rapid growth in the next few years. It will grow to $4.81 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to an increasing prevalence of chronic diseases, growth in genomic projects, development of ipsc-derived disease models, an increasing prevalence of genetic diseases, government initiatives and a rapid increase in technology. Major trends in the forecast period include development of pluripotent stem cells for parkinson's disease (pd), strategic collaborations and partnerships, development of induced pluripotent stem cell ipsc-derived nk cells, development of induced pluripotent stem cell (ipsc) for cell therapy, investment in regenerative medicine research and development, development of ipsc expansion medium, development of personalized ipsc and development of pluripotent stem cells for type i diabetes.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

Market Segmentation:
The induced pluripotent stem cell (ipsc) market covered in this report is segmented -

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy
3) By End-User: Hospitals, Research Laboratories

Major Driver - Rising Chronic Disorders Prevalence Driving Growth In The Induced Pluripotent Stem Cell Market
An increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of the induced pluripotent stem cell market. Chronic disorders such as heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell. Induced Pluripotent stem cells are taken from any tissues from a child or an adult and are genetically modified to behave such as embryonic stem cells. According to the report published by Partnership to Fight Chronic Disorder (PFCD), it was found that out of 133 million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is driving the demand for induced pluripotent stem cell treatment market.

Competitive Landscape:
Major companies operating in the induced pluripotent stem cell (ipsc) market report are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Banco de Cordon del Peru, CryoHoldco, CellSave Arabia, Life Cell, AmiCare, Cells4life, ReeLabs, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Top Trend - Strategic Collaborations Drive Expansion In The Induced Pluripotent Stem Cell Market
Companies in the Induced Pluripotent stem cell market are looking for opportunities for strategic partnerships and collaborations that will help these companies to enter into new geographies and to expand product portfolios. For example, in January 2022, Bristol Myers Squibb and Century Therapeutics entered into a strategic collaboration to develop iPSC-derived allogenic cell therapies for the treatment of acute myeloid leukemia and multiple myeloma. Furthermore, in May 2022, Evotec and Sernova announced strategic partnership to develop iPSC-based beta cell replacement therapy for treatment for type 1 and type 2 diabetes.

The Table Of Content For The Market Report Include:

1. Executive Summary
2. Induced Pluripotent Stem Cell (iPSC) Market Characteristics
3. Induced Pluripotent Stem Cell (iPSC) Market Trends And Strategies
4. Induced Pluripotent Stem Cell (iPSC) Market - Macro Economic Scenario
5. Induced Pluripotent Stem Cell (iPSC) Market Size And Growth
…..
27. Induced Pluripotent Stem Cell (iPSC) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Induced Pluripotent Stem Cell (iPSC) Market Growth, Size, Trends, Size, Share And Analysis Report 2024-2033 here

News-ID: 3424209 • Views:

More Releases from The Business research company

Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Multi-Fiber Push On (MPO) or Mechanical Transfer Push-On (MTP) Cabling Assemblies Market
Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influenci …
The multi-fiber push on (MPO) or mechanical transfer push-on (MTP) cabling assemblies market is on track for significant expansion in the coming years, driven by advancements in data transmission technology and increasing demand for efficient connectivity solutions. As digital transformation accelerates across industries, these cabling assemblies are becoming essential components in modern network infrastructure. Below is a detailed overview of the market's size, key drivers, leading players, trends, and main
Analysis of Key Market Segments Driving the Microproteins Skincare Market
Analysis of Key Market Segments Driving the Microproteins Skincare Market
The microproteins skincare market is gaining significant traction as consumers increasingly seek effective, science-driven beauty solutions. With innovations in peptide technology and a growing focus on personalized skincare, this market is on a promising growth trajectory. Let's explore the current market size, leading players, influential trends, and segmentation details shaping this dynamic sector. Projected Growth and Market Size of the Microproteins Skincare Market The microproteins skincare market is projected to experience robust
Market Trend Analysis: The Impact of Recent Innovations on the Medical Device Brazing Service Market
Market Trend Analysis: The Impact of Recent Innovations on the Medical Device Br …
The medical device brazing service market is on track for substantial growth in the coming years, driven by advancing technologies and evolving healthcare needs. As the demand for reliable and efficient medical devices rises, the brazing services that enable precision joining of components are becoming increasingly vital. Let's explore the market size projections, key players, segmentation details, and emerging trends shaping this industry. Medical Device Brazing Service Market Size and Growth
Segmentation, Major Trends, and Competitive Overview of the Lifestyle-Related Disease Supplements Market
Segmentation, Major Trends, and Competitive Overview of the Lifestyle-Related Di …
The lifestyle-related disease supplements market is rapidly evolving as consumers become more health-conscious and proactive about managing chronic conditions linked to lifestyle choices. With an aging global population and increasing disposable incomes, this sector is set for impressive growth. Let's explore the market size, key players, trends, and segmentation that are shaping its future trajectory. Projected Market Size and Growth Rate for Lifestyle-Related Disease Supplements The lifestyle-related disease supplements market is on

All 5 Releases


More Releases for Cell

Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting. Download Full PDF Sample Copy
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging